Skip to main content
. 2022 Feb 25;14(5):1188. doi: 10.3390/cancers14051188

Table 2.

Postoperative findings, N = 115.

Variables N (%) Median
In-hospital stay (days) - 10 (6–41)
Histopathological entity
malignant 71 (61.7%)
benign 44 (38.3%)
UICC classification
Stage 0 (after neoadjuvant therapy) 8 (7.0%)
Stage I 20 (17.4%)
Stage II 24 (20.9%)
Stage III 16 (13.9%)
Stage IV 3 (2.6%)
Clavien-Dindo classification (CDC)
Grade IIIa 5 (4.3%)
Grade IIIb 2 (1.7%)
Grade IV 1 (0.9%)
Anastomotic leakage 8 (6.9%)